University of Colorado Cancer Center Blog Archive
Head over to the new CU Cancer Center blog to see the latest research, patient stories, and more from the center.
Advanced technologies for cancer research aid the fight against COVID-19
CU Cancer Center clinical psychologist offers mental health tips for patients with cancer during COVID-19.
Blocking metabolic pathways could help doctors stop COVID-19 associated blood clots
“I know directly from my research that a tan is damage,” says Neil Box, PhD.
“Medical situations are the explosions we run toward rather than away from.”
From basic science to clinical trials, CU Cancer Center moving the needle on cancer discovery and care
“For some people, a sunburn could be as dangerous as a virus exposure,” says Neil Box, PhD.
The CU Cancer Center is excited to announce that Chris Lieu, MD, is the Associate Director of Clinical Research
Variation in how side effects are reported leaves first impressions of new anti-cancer drugs open to manipulation
Differences in side effect reporting makes some drugs seem safer or less safe than they really are
From 40-70 percent in the 1990s, to 20-25 percent in the early 2000s, to 19.9 percent today.
The Colorado Cancer Screening Program (CCSP) for Patient Navigation is working with the safety net clinics throughout Colorado to help respond to the coronavirus and COVID-19.
Right-colon twist with high-dose osimertinib highlights need for doctor vigilance with new cancer drugs
After being told her tumor was inoperable, Nancy White turns to CU Cancer Center and undergoes lifesaving surgery
“By the time a patient diagnosed today finishes their treatment, maybe we’ll all be ready to get back to our lives.”
CU study shows cells don’t depend on a snapshot to decide whether to replicate – it’s more like a movie.
Benjamin Bitler, PhD Most ovarian cancer starts in fallopian tubes. Then it sloughs from its site of origin and floats around in fluid until finding new sites of attachment. It’s not easy for cancer cells to survive away from their moorings. Observations by ovarian...
“The results were surprising and encouraging,” says Adam Green, MD.
His challenge: to help navigate a paradigm shift in the way we prevent, diagnose, and treat the disease.
“Two independent sources with the same scientific finding make you think it’s true.”
Could medicines that activate the immune system *protect* against COVID-19 infection?
“I tell patients they should call their provider with any new symptom, says Ryan Weight, DO, MS.
Post-diagnosis disparities drive poorer outcomes for pediatric Black and Hispanic brain cancer patients
52 percent of White patients lived five years from diagnosis; only 44 percent of African American patients and 45 percent of Hispanic patients reached a similar milestone.
African American patients about half as likely as non-Hispanic whites to receive PET-CT imaging
Heather Leach, PhD, wants to get cancer survivors moving and keep them moving!
“Cancer patients should take the same precautions as others in high-risk populations,” says Thomas Campbell, MD
Lydia Mallernee was diagnosed in March 2018 with advanced cancer of the bile duct. After receiving an IV immunotherapy, she has no evidence of disease since August 2019.
Nicole and David Garrett face the question of fertility preservation in their 4-year-old
Feb 29, 2020 event for all ages/abilities!
HO-1 may help TNBC hide from the immune system — and a drug already exists to stop it.
All we really needed to know about cancer comes from an 8-year-old on the Pearl Street Mall.